Dr. Matthew S. Davids
Claim this profileDana Farber Cancer Institute
Studies Chronic Lymphocytic Leukemia
Studies Richter Syndrome
12 reported clinical trials
21 drugs studied
Area of expertise
1Chronic Lymphocytic Leukemia
TP53 positive
Del(17p) positive
2Richter Syndrome
Stage IV
Affiliated Hospitals
Clinical Trials Matthew S. Davids is currently running
Glofitamab Combinations
for Richter's Transformation
This research is being done to evaluate Glofitamab by itself or in combination with Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab as possible treatments for Chronic Lymphocytic Leukemia (CLL) that has transformed into Richter's Transformation (RT). The names of the study drugs involved in this research study are: * Glofitamab (a T-cell bispecific humanized monoclonal antibody) * Obinutuzumab (a humanized glycoengineered type II anti-CD20 monoclonal antibody) * Polatuzumab vedotin (an antibody-drug conjugate) * Pirtobrutinib (a selective inhibitor of BTK) * Atezolizumab (a humanized immunoglobulin monoclonal antibody) * Tocilizumab (a recombinant, humanized, anti-human monoclonal antibody)
Recruiting1 award Phase 217 criteria
Venetoclax + Obinutuzumab +/- Acalabrutinib
for Chronic Lymphocytic Leukemia
This research study is studying a combination of drugs as a possible treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The names of the study drugs involved in this study are: * obinutuzumab * venetoclax * acalabrutinib
Recruiting3 awards Phase 218 criteria
More about Matthew S. Davids
Clinical Trial Related11 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Matthew S. Davids has experience with
- Venetoclax
- Obinutuzumab
- Cyclophosphamide
- Rituximab
- Fludarabine
- Ibrutinib
Breakdown of trials Matthew S. Davids has run
Chronic Lymphocytic Leukemia
Richter Syndrome
Leukemia
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew S. Davids specialize in?
Matthew S. Davids focuses on Chronic Lymphocytic Leukemia and Richter Syndrome. In particular, much of their work with Chronic Lymphocytic Leukemia has involved TP53 positive patients, or patients who are Del(17p) positive.
Is Matthew S. Davids currently recruiting for clinical trials?
Yes, Matthew S. Davids is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Matthew S. Davids has studied deeply?
Yes, Matthew S. Davids has studied treatments such as Venetoclax, Obinutuzumab, Cyclophosphamide.
What is the best way to schedule an appointment with Matthew S. Davids?
Apply for one of the trials that Matthew S. Davids is conducting.
What is the office address of Matthew S. Davids?
The office of Matthew S. Davids is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02284 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.